Bernice Ellis

Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein

Wolfgang Glaesner, Andrew Vick, Rohn Millican et al. · Diabetes/Metabolism Research and Reviews · 2010 · 295 citations

Pharmacy, Endocrinology, Pharmacology +17

The separation of o-phthalaldehyde derivatives of amino acids by reversed-phase chromatography on octylsilica columns

Harry W. Jarrett, K.D. Cooksy, Bernice Ellis et al. · Analytical Biochemistry · 1986 · 195 citations

Natural Sciences, Biochemistry, Chemistry +16

A New Reagent for Detection of Peptides, Nucleotides, and Other N—H-containing Compounds on Paper Chromatograms

Robert H. Mazur, Bernice Ellis, Peter S. Cammarata · Journal of Biological Chemistry · 1962 · 147 citations · Full text

Natural Sciences, Biochemistry, Chemistry +9

A 5‐week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long‐acting glucagon‐like peptide‐1 analogue, in patients with type 2 diabetes

Peggy L. Barrington, Jenny Y. Chien, H. D. Hollis Showalter et al. · Diabetes Obesity and Metabolism · 2011 · 120 citations

Medicine, Pharmacokinetics, Pharmacology +17

LY2189265, a long‐acting glucagon‐like peptide‐1 analogue, showed a dose‐dependent effect on insulin secretion in healthy subjects

Peggy L. Barrington, Jenny Y. Chien, Fabián Tibaldi et al. · Diabetes Obesity and Metabolism · 2011 · 73 citations

Medicine, Endocrinology, Pharmacology +15